Mandate

Vinge advises Saab in connection with the sale of C3 Technologies

July 14, 2011

Vinge has advised Saab in connection with the sale of the entire issued share capital of C3 Technologies. Saab is the company’s majority shareholder and the company itself is a spin-off from Saab which offers 3D-data to the consumer market based on Saab’s 3D map technology. Saab received a purchase price of approximately SEK 1 billion, which resulted in a profit to Saab of approximately SEK 900 million. The transaction is subject to customary competition law approvals.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Johan Larsson, Johan Mattsson, Adam Weissbach and Malin Buch as well as project assistants Ida Norlin and Mikaela Mars. Partners Per Eric Alvsing and Karin Grauers and associates Claes Henriksson and Daniel Järmén provided IP law advice.  

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026